Lawrence: /* Sample Size */

2025-06-04T14:29:25Z

Sample Size

← Older revision		Revision as of 14:29, 4 June 2025
Line 5:		Line 5:
	=== Eligibility Criteria ===		=== Eligibility Criteria ===

	Defining clear inclusion and exclusion criteria is essential. Inclusion criteria specify the characteristics participants must have to enroll in the study, such as age range, confirmed diagnosis, or baseline severity of disease. For example, a trial on type 2 diabetes may include adults aged 18–65 with HbA1c above a certain threshold. Exclusion criteria identify characteristics that disqualify individuals due to safety concerns or confounding risk. Common examples include specific comorbidities (e.g., severe kidney disease), recent use of contraindicated medications, or pregnancy. These criteria help create a study population that is appropriate for the research question while minimizing risks.		Defining clear inclusion and exclusion criteria is essential. Inclusion criteria specify the characteristics participants must have to enroll in the study, such as age range, confirmed diagnosis, or baseline severity of disease. For example, a trial on type 2 diabetes may include adults aged 18–65 with HbA1c above a certain threshold. Exclusion criteria identify characteristics that disqualify individuals due to safety concerns or confounding risk. Common examples include specific comorbidities (e.g., severe kidney disease), recent use of contraindicated medications, or pregnancy. These criteria help create a study population that is appropriate for the [[research question]] while minimizing risks.

	=== Representativeness and Generalizability ===		=== Representativeness and Generalizability ===
Line 21:		Line 21:
	=== Vulnerable Populations ===		=== Vulnerable Populations ===

	Special care is required when involving vulnerable populations, such as children, older adults, pregnant individuals, or incarcerated persons. Ethical considerations include enhanced informed consent procedures, ongoing monitoring, and additional protections to minimize the risk of coercion or harm. Ethics review boards typically require justification and safeguards when these groups are included.		Special care is required when involving vulnerable populations, such as children, older adults, pregnant individuals, or incarcerated persons. Ethical considerations include enhanced [[informed consent]] procedures, ongoing monitoring, and additional protections to minimize the risk of coercion or harm. [[Ethics]] review boards typically require justification and safeguards when these groups are included.

	=== Risk of Attrition ===		=== Risk of Attrition ===
Line 41:		Line 41:
	=== Sample Size ===		=== Sample Size ===

	An appropriate sample size is crucial for detecting meaningful differences between groups. Power calculations must account for the expected effect size, variability, and study design. Additionally, expected dropout should be factored in, ensuring enough participants are enrolled to maintain statistical power by the study’s end.		An appropriate [[sample size]] is crucial for detecting meaningful differences between groups. Power calculations must account for the expected effect size, variability, and study design. Additionally, expected dropout should be factored in, ensuring enough participants are enrolled to maintain statistical power by the study’s end.

			----

			=== Bibliography ===

			# Schulz KF, Altman DG, Moher D; for the [[CONSORT]] Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. ''Annals of Internal Medicine''. 2010;152(11):726–732.
			# Fletcher RH, Fletcher SW, Fletcher GS. Clinical Epidemiology: The Essentials. 5th ed. Wolters Kluwer; 2014.
			# Treweek S, Lockhart P, Pitkethly M, et al. Methods to improve recruitment to randomised controlled trials: Cochrane [[systematic review]] and meta-[[analysis]]. ''BMJ Open''. 2013;3(2):e002360.
			# Caldwell PHY, Murphy SB, Butow PN, Craig JC. Clinical trials in children. ''The Lancet''. 2004;364(9436):803–811.
			# George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. ''American Journal of Public Health''. 2014;104(2):e16–e31.

			----
			''Adapted for educational use. Please cite relevant trial methodology sources when using this material in research or teaching.''

Lawrence: Created page with "== Trial participants == Selecting and managing participants is a critical component of designing a successful Randomized Controlled Trial (RCT). The characteristics and treatment of participants directly influence a trial’s validity, feasibility, and generalizability. A well-considered participant strategy ensures the trial population reflects the study’s goals and that ethical, practical, and statistical needs are met. === Eligibility Criteria === Defining clear..."

2025-03-25T19:44:33Z

Created page with "== Trial participants == Selecting and managing participants is a critical component of designing a successful Randomized Controlled Trial (RCT). The characteristics and treatment of participants directly influence a trial’s validity, feasibility, and generalizability. A well-considered participant strategy ensures the trial population reflects the study’s goals and that ethical, practical, and statistical needs are met. === Eligibility Criteria === Defining clear..."

New page

== Trial participants ==

Selecting and managing participants is a critical component of designing a successful Randomized Controlled Trial (RCT). The characteristics and treatment of participants directly influence a trial’s validity, feasibility, and generalizability. A well-considered participant strategy ensures the trial population reflects the study’s goals and that ethical, practical, and statistical needs are met.

=== Eligibility Criteria ===

Defining clear inclusion and exclusion criteria is essential. Inclusion criteria specify the characteristics participants must have to enroll in the study, such as age range, confirmed diagnosis, or baseline severity of disease. For example, a trial on type 2 diabetes may include adults aged 18–65 with HbA1c above a certain threshold. Exclusion criteria identify characteristics that disqualify individuals due to safety concerns or confounding risk. Common examples include specific comorbidities (e.g., severe kidney disease), recent use of contraindicated medications, or pregnancy. These criteria help create a study population that is appropriate for the research question while minimizing risks.

=== Representativeness and Generalizability ===

Participants should be representative of the population that would use the intervention in real-world settings. A diverse sample enhances external validity by including variation in age, sex, race/ethnicity, socioeconomic status, and geographic region. However, a balance is needed: overly restrictive criteria may improve internal validity but reduce generalizability, while broad criteria may do the opposite. Trialists should define participant characteristics that reflect the intervention’s intended use population.

=== Recruitment Feasibility ===

Recruitment must be achievable within the study’s time and resource constraints. Researchers should assess whether the target population is accessible and identify feasible recruitment sites, such as hospitals, clinics, community centers, or online platforms. Effective recruitment strategies may include community outreach, partnerships with local organizations, or the use of incentives. Planning for recruitment should begin early and account for potential barriers to enrollment.

=== Participant Commitment and Compliance ===

Successful trials rely on participant adherence to study protocols. Trialists should consider whether participants can realistically complete all study activities, including intervention delivery and follow-up visits. Factors such as travel requirements, intervention complexity (e.g., daily medications or scheduled exercise), and study duration can affect compliance. These should be evaluated during trial planning and addressed through participant-friendly design.

=== Vulnerable Populations ===

Special care is required when involving vulnerable populations, such as children, older adults, pregnant individuals, or incarcerated persons. Ethical considerations include enhanced informed consent procedures, ongoing monitoring, and additional protections to minimize the risk of coercion or harm. Ethics review boards typically require justification and safeguards when these groups are included.

=== Risk of Attrition ===

Participant dropout (attrition) can undermine trial validity and statistical power. Researchers should assess attrition risk and plan retention strategies in advance. High-risk groups might include individuals with unstable housing, chronic illnesses, or demanding schedules. To reduce dropout rates, consider regular communication, reminder systems, participant incentives, and flexibility in scheduling.

=== Health Status and Comorbidities ===

Participants’ baseline health conditions may influence both the safety and effectiveness of the intervention. Trials must balance the inclusion of participants with common comorbidities to reflect real-world practice, while avoiding individuals with conditions that pose safety concerns. This balance supports generalizability without compromising participant well-being.

=== Willingness and Motivation ===

Motivated participants are more likely to adhere to the intervention and complete required assessments. Willingness can be gauged during the recruitment phase through interviews or screening surveys. Providing clear information about the study’s purpose, expectations, and potential benefits can enhance motivation and improve overall engagement.

=== Ethical and Cultural Considerations ===

Respect for cultural norms and participant backgrounds is essential throughout the recruitment and trial process. This includes using culturally sensitive communication, accommodating language differences, and tailoring consent materials for varying literacy levels. Informed consent procedures should be designed to ensure that all participants understand their involvement and rights within the study.

=== Sample Size ===

An appropriate sample size is crucial for detecting meaningful differences between groups. Power calculations must account for the expected effect size, variability, and study design. Additionally, expected dropout should be factored in, ensuring enough participants are enrolled to maintain statistical power by the study’s end.

Trial participants - Revision history

Lawrence: /* Sample Size */